Lupin Q2 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
1,955.80
-3.40 (-0.17%)
-3.40 (-0.17%)Volume30.59 K
Updated: Fri 16 Oct, 2026 | 15:29:02
NSE
1,961.60-19.30 (-0.97%)
-19.30 (-0.97%)Volume7.29 L
Updated: Fri 16 Oct, 2026 | 15:50:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Lupin Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,226.68 | 6,266.29 | 6.11% | 4,621.37 | 13.10% |
| Depreciation/ Amortization | 316.77 | 452.85 | 5.95% | 256.92 | 23.30% |
| Operating Income | 1,820.83 | 2,010.60 | 35.64% | 1,051.36 | 73.19% |
| Net Income | 1,477.92 | 1,415.00 | 21.24% | 852.58 | 73.35% |
| Other Operating Expenses Total | 1,979.58 | 2,341.20 | 11.71% | 1,666.99 | 18.75% |
| Net Income Before Taxes | 2,006.97 | 2,017.38 | 41.78% | 1,054.86 | 90.26% |
| Total Revenue | 7,047.51 | 8,276.89 | 12.43% | 5,672.73 | 24.23% |
| Selling/ General/ Admin Expenses Total | 1,105.56 | 1,383.00 | 2.08% | 1,007.52 | 9.73% |
| Diluted Normalized EPS | 32.28 | 30.89 | 21.26% | 18.64 | 73.20% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.